Kevin R Sayer

Executive Chair, Director, Dexcom

Bought, 12 months

$0.0M

Sold, 12 months

$8.3M

Companies

Latest trade

Aug 20, 2026

Companies

DexcomExecutive Chair, Director −$8.3M

Trades

DXCM Sold 26,756 shares at $90.01 · planned $2.4M Aug 20

DXCM Sold 26,756 shares at $76.32 · planned $2.0M Jul 20

DXCM Sold 26,756 shares at $72.00 · planned $1.9M Jul 6

DXCM Sold 26,759 shares at $72.00 · planned $1.9M May 21

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.